German-based startup attracts venture funding from leading European VC firms to address ‘Agitation/Aggression’ in Alzheimer’s disease
GTP Bioways invests € 12M in two GMP biopharmaceutical production units
GTP Bioways strengthens position as leading CDMO in Europe by opening two new biopharmaceutical production units at Toulouse site
GTP Bioways will become the unique CDMO in France with this offer, based on two new lines, one focused on microbial production, the other on small-scale mammalian-based production
Minafin reorganizes to meet customer challenges in fine chemicals
ADVENT FRANCE BIOTECHNOLOGY LAUNCHES ITS SECOND FUND WITH A FIRST CLOSE AT €86M ($102M)
• Strong first closing confirms relevance of AFB’s unique early-stage investment strategy; aiming to create, develop and finance promising European life sciences startups in innovative therapeutics
• Since 2017, AFB’s €68M ($80M) first fund – Advent France Biotechnology Seed-Fund I – has successfully financed 15 startups in France, Spain, Belgium and Ireland
New startup aglaia therapeutics raises €4m in seed funding to overcome resistance in oncology targeted therapies
Venture capital firm Advent France Biotechnology led fundraising, alongside Crédit Mutuel Innovation and Pierre Fabre
Co-founded by AFB and leading cancer institutes Gustave Roussy and Institut Curie, startup will use funding to prepare essential preclinical work to identify first oncology program to develop
Banook group acquires german counterpart Nabios gmbh to become a European leader in cardiac safety services
First external acquisition allows Banook Group to strengthen its presence in Central and Eastern Europe
Hephaï receives 2021 Catalyst Award from US National Academy of Medicine for its unique digital education platform
L’Afssi dresse l’état des lieux des services de r&d dans les sciences de la vie en France lors des 8e Afssi connexions
Avec la crise sanitaire, les sociétés françaises de services et d’innovation en sciences de la vie ont pu montrer leur capacité d’adaptation, leur agilité et leur réactivité pour faire avancer la recherche en santé
L’édition 2021 des AFSSI Connexions, les 28 et 29 septembre, est l’occasion de mettre en avant le poids de la filière dans les enjeux de compétitivité et de souveraineté nationale en recherche dans la santé
Advent France Biotechnology crée Thabor Therapeutics et finance son amorçage
Les fonds apportés vont permettre à la nouvelle start-up de développer une approche thérapeutique innovante pour les patients atteints de maladies inflammatoires chroniques
